Dana-Farber Cancer Institute Boston
#1 Cancer Center in USA & New England • Harvard Medical School • Global Pioneer in Cellular Therapy
Institute Overview
Dana-Farber Cancer Institute, affiliated with Harvard Medical School and part of Dana-Farber/Brigham and Women’s Cancer Center, is ranked #1 for cancer in the United States and New England (U.S. News & World Report 2025). It is one of the world’s most innovative cancer centers, leading in cellular immunotherapy, precision medicine, and early-phase clinical trials.
Global Leadership in Cellular Immunotherapy
CAR-T & TIL Therapy
- All 6 FDA-approved CAR-T products available
- One of the first centers worldwide to offer commercial TIL therapy (Amtagvi)
- Leading site for next-gen CAR-T, bispecifics, and allogeneic platforms
Pediatric Oncology
- Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
- #1 pediatric cancer program in New England
- World leader in pediatric CAR-T and rare tumors
Research & Trials
- Over 700 active clinical trials
- Home of the first cancer vaccine trials
- Largest phase I program in New England
Cost Comparison – Dana-Farber vs Global Centers (2025)
| Treatment | Dana-Farber USA | Cleveland Clinic | Asan Korea | Bumrungrad | CAMS China |
|---|---|---|---|---|---|
| CAR-T Therapy | $450K–$550K | $450K–$550K | $300K–$400K | Not available | $45K–$70K |
| TIL Therapy (Amtagvi) | $515,000 | $515,000 | Not available | Not available | Trials only |
| Phase I Trial Access | Top 3 USA | Top 10 USA | Moderate | Limited | Growing |
Available Advanced Treatments
| Treatment | Availability |
|---|---|
| All 6 FDA CAR-T Products | Available |
| FDA-Approved TIL Therapy (Amtagvi) | Leading Center |
| Bispecific Antibodies | Available |
| Phase I/II Clinical Trials | Top 3 in USA |
| Precision Oncology & Liquid Biopsy | World Leader |
| Pediatric CAR-T & Rare Tumors | #1 in New England |
Frequently Asked Questions
Contact & Location
Main Campus
450 Brookline Avenue
Boston, MA 02215
United States
International Patients
Phone: +1-617-632-3000
International Office: +1-617-632-5456
Email: international@dfci.harvard.edu
Ready for Treatment at the #1 Cancer Center in America?
Get access to the world’s most advanced immunotherapy, TIL therapy, and phase I trials at Dana-Farber.
Request Free Consultation